How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review

BACKGROUND: The treatments of COVID-19 involve some degree of uncertainty. Current evidence also shows mixed findings with regards to bioaerosol dispersion and airborne transmission of COVID-19 during high flow nasal cannula (HFNC) therapy. While coping with this global pandemic created hot debates...

Descripción completa

Detalles Bibliográficos
Autores principales: Ari, Arzu, Moody, Gerald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Society of Respiratory Therapists 2021
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932031/
https://www.ncbi.nlm.nih.gov/pubmed/33688576
http://dx.doi.org/10.29390/cjrt-2020-041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932031/
https://www.ncbi.nlm.nih.gov/pubmed/33688576
http://dx.doi.org/10.29390/cjrt-2020-041

Ejemplares similares